# Human Telomerase Reverse Transcriptase Messenger RNA (hTERT mRNA) Transfected Dendritic Cell Vaccines

> **NCT01153113** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **University of Florida**

## Conditions studied

- Metastatic Prostate Cancer

## Interventions

- **BIOLOGICAL:** hTERT mRNA DC
- **BIOLOGICAL:** hTERT mRNA DC

## Key facts

- **NCT ID:** NCT01153113
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-01
- **Primary completion:** 2009-12
- **Final completion:** 2010-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** IND has been withdrawn and the study is closed.
- **Last updated:** 2011-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01153113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01153113, "Human Telomerase Reverse Transcriptase Messenger RNA (hTERT mRNA) Transfected Dendritic Cell Vaccines". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01153113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*